Skip to main content

Table 1 Concomitant chemotherapy regimens ( n = 76)

From: Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy

Concomitant chemotherapy regimens

Cycles

Patients number ( n)

Vinorelbine (20 mg/m2, days 1, 8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days.

2

5

Vinorelbine (25 mg/m2, days 1, 8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days.

2

36

Docetaxel (30 mg/m2, days 1, 8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days.

2

6

Docetaxel (35 mg/m2, days 1, 8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days.

2

28

Docetaxel (40 mg/m2, days 1,8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days.

2

1

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us